Calamos Advisors LLC Has $11.80 Million Position in Corteva (NYSE:CTVA)

Calamos Advisors LLC reduced its holdings in Corteva (NYSE:CTVA) by 0.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 399,295 shares of the company’s stock after selling 2,909 shares during the quarter. Calamos Advisors LLC’s holdings in Corteva were worth $11,803,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of the company. Catalyst Capital Advisors LLC grew its position in Corteva by 261.2% during the third quarter. Catalyst Capital Advisors LLC now owns 939 shares of the company’s stock worth $26,000 after buying an additional 679 shares in the last quarter. Acima Private Wealth LLC acquired a new stake in Corteva during the third quarter worth about $27,000. Compagnie Lombard Odier SCmA acquired a new stake in Corteva during the second quarter worth about $29,000. Advantage Investment Management LLC grew its position in Corteva by 101.0% during the third quarter. Advantage Investment Management LLC now owns 1,021 shares of the company’s stock worth $29,000 after buying an additional 513 shares in the last quarter. Finally, Massmutual Trust Co. FSB ADV acquired a new stake in Corteva during the second quarter worth about $30,000. 74.91% of the stock is currently owned by institutional investors.

In related news, EVP Timothy P. Glenn acquired 5,150 shares of the firm’s stock in a transaction on Monday, November 4th. The shares were bought at an average cost of $26.13 per share, with a total value of $134,569.50. Also, SVP Cornel B. Fuerer acquired 2,000 shares of the firm’s stock in a transaction on Monday, November 4th. The shares were bought at an average cost of $26.13 per share, for a total transaction of $52,260.00. Insiders have acquired 15,975 shares of company stock worth $414,277 over the last ninety days.

NYSE CTVA opened at $28.68 on Thursday. The stock’s 50 day moving average is $27.48 and its two-hundred day moving average is $27.83. Corteva has a 1-year low of $24.10 and a 1-year high of $32.78.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Thursday, October 31st. The company reported ($0.39) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.46) by $0.07. The company had revenue of $1.91 billion for the quarter, compared to analyst estimates of $1.97 billion. The firm’s revenue for the quarter was down 1.8% compared to the same quarter last year. On average, sell-side analysts predict that Corteva will post 1.23 EPS for the current year.

A number of equities research analysts recently weighed in on the company. Citigroup decreased their target price on Corteva from $34.50 to $31.00 and set a “buy” rating on the stock in a research report on Wednesday, October 9th. Barclays set a $32.00 target price on Corteva and gave the stock a “hold” rating in a research report on Friday, November 1st. UBS Group decreased their target price on Corteva from $33.00 to $32.00 and set a “buy” rating on the stock in a research report on Thursday, December 19th. Vertical Research assumed coverage on Corteva in a research report on Thursday, December 19th. They set a “hold” rating and a $27.00 target price on the stock. Finally, JPMorgan Chase & Co. downgraded Corteva from an “overweight” rating to a “neutral” rating and decreased their target price for the stock from $30.00 to $27.00 in a research report on Friday, November 1st. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and eight have given a buy rating to the stock. Corteva presently has a consensus rating of “Hold” and an average price target of $30.80.

About Corteva

Corteva, Inc provides agriculture products worldwide. The company develops and supplies germplasm and traits in corn, soybean, and sunflower seed markets. It also supplies products to the agricultural input industry that protect against weeds, insects and other pests, and diseases, as well as to enhance crop health.

Further Reading: Correction

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva (NYSE:CTVA).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.